目的 了解人血白蛋白在本院消化道肿瘤患者中的使用情况,促进该药的合理使用。方法 采用回顾性分析方法,随机抽取本院2016年8月至2018年1月应用人血白蛋白的360例消化道肿瘤住院患者病例,对患者的基本资料、手术部位、应用人血白蛋白的适应证、手术前后血清白蛋白浓度等进行统计分析。结果 人血白蛋白平均使用量为(17.39±7.13)g,平均疗程为(5.36±3.16)d,用药前患者血清白蛋白水平大部分为26~35 g·L-1,手术部位主要为胃部,适应证主要为低蛋白血症,术前即存在低蛋白血症者占31.4%,术前正常而术后出现低蛋白血症者占66.7%。结论 人血白蛋白在本院消化道肿瘤患者中的合理使用还需加强。
Abstract
OBJECTIVE To evaluate the use of human serum albumin in gastrointestinal tumor patients of our hospital, and promote the rational use of the drug. METHODS By adopting retrospective analysis, 360 medical records of gastrointestinal tumor inpatients administered with human serum albumin in our hospital during August 2016 to January 2018 were selected randomly to analyze the basic data,the surgical site, the indications of human serum albumin and the concentration of serum albumin before and after the operation. RESULTS The average use amount of human serum albumin was (17.39±7.13) g, the average course was (5.36±3.16) d, serum albumin concentration of the most patients before drug administration was 26-35 g·L-1, the main surgery site was gastricarea,the indication for using human serum albumin was mainly hypoproteinemia,preoperative hypoproteinemia patients accounted for 31.4%, and postoperative hypoproteinemia patients accounted for 66.7%. CONCLUSION The rational use of human serum albumin in gastrointestinal tumor patients needs to be strengthened.
关键词
人血白蛋白 /
消化道肿瘤 /
低蛋白血症 /
合理使用
{{custom_keyword}} /
Key words
human serum albumin /
gastrointestinal tumor /
hypoproteinemia /
specification use
{{custom_keyword}} /
中图分类号:
R969
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XIAO T Y, WANG B. Asurveyand analysis on the clinical application of human serum albumin [J]. Chin Pharm J(中国药学杂志),2010, 45(13):1035-1038.
[2] ZHONG F Z, YANG S L. Common misunderstandings in the application of human serum albumin during perioperative period [J]. Med Front(医药前沿), 2012, (25):174-175.
[3] MOUJAESS E, FAKHOURY M, ASSI T, et al. The therapeutic use of human albumin in cancer patients′ management[J]. Crit Rev Oncol Hematol, 2017, 120:203-209.
[4] LIU Z, KONG Y J, LI L. The medical value of albumin: whether need to be reassessed[J]. Chin J Blood Transfus(中国输血杂志),2018, 31(1):1-3.
[5] LI D J, LIANG D, JIN J, et al. Epidemiological trend of upper gastrointestinal cancer[J]. J Cancer Control Treat(肿瘤预防与治疗), 2018, 31(1):62-68.
[6] DU Y Q, CAI Q C, LIAO Z, et al. China experts consensus on the protocol of early gastric cancer screening (2017,Shanghai)[J]. Chin J Gastroenter(胃肠病学), 2018, 2:92-97.
[7] GATTA A, VERARDO A, BOLOGNESI M. Hypoalbuminemia[J]. Intern Emerg Med, 2012,7(suppl 3):S193-199.
[8] CHEN X L, XUE L, WANG W, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma:a retrospective cohort study[J]. Oncotarget, 2015, 6(38):41370-41382.
[9] BELLOMO R, BOYCE N, FRENCH J, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit[J]. N Engl J Med, 2004, 350(22):2247-2256.
[10] DUBOIS M J, ORELLANA-JIMENEZ C, MELOT C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients:a prospective, randomized, controlled, pilot study[J]. Crit Care Med, 2006, 34(10):2536-2540.
[11] CHENG J, WU H, WU G C, et al. Establishmentof evaluation standards for clinical use of human serum albumin in our hospital based on evidence-based medicine[J]. J Chin Pharm(中国药房), 2017, 28(2):257-261.
[12] LUO Z, WEI B D.To study the safety and efficacy of exogenous albumin in the treatment of critical patients ingastrointestinal surgery[J]. Med Inform(医学信息),2014,27(2):33.
[13] CRUMLEY A B, STUART R C, MCKERNAN M, et al. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer[J]. World J Surg, 2010, 34(10):2393-2398.
[14] ZHENG H L, LU J, LI P, et al. Effects of preoperative malnutrition on Short-and Long-Term Outcomes of patients with gastric cancer:can we do better[J]. Ann Surg Oncol, 2017, 24(11):3376-3385.
[15] YUAN X Y, ZHANG C H, HE Y L, et al. Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery:a prospective randomized controlled trial[J]. Am J Surg, 2008, 196(5):751-755.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}